• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Cyber gang threatens to release Henry Schein data in ransomware attack

Cyber gang threatens to release Henry Schein data in ransomware attack

November 3, 2023 By Jim Hammerand

Henry Schein Logo 770x500A cyberattack group known as BlackCat is threatening to release Henry Schein (Nasdaq: HSIC) data unless the medical device manufacturer and distributor pays a ransom.

BlackCat (also known as ALPHV, both named after the ransomware of the same name) said they’ve encrypted Henry Schein’s systems after failed negotiations with Coveware, which describes itself as “ransomware recovery first responders.”

The cyber gang said they’ve stolen 35 TB of “sensitive data,” including “internal payroll data and shareholder folders.”

Henry Schein disclosed a cyber security incident on October 15 and has offered few details.

The latest update came in a Securities and Exchange Filing this week asking for more time to file its quarterly report for the three months ended Sept. 30. The company said it wouldn’t be able to file on time “due to information access limitations arising from the company’s decision to shut down certain operations as a precautionary measure as a result of the cybersecurity incident.”

The BlackCat/ALPHV group reportedly added Henry Schein to its dark web leak site last month. This week, the group threatened to post data as soon as today and said it has already cost Henry Schein $150 million.

The group later removed Henry Schein from its leak site, which could mean negotiations have resumed or the company has paid the ransom.

Cybersecurity expert Dominic Alvieri posted a screenshot of ALPHV/BlackCat’s threats and called them the “most dangerous, damaging and flexible ransomware group today,” citing the Henry Schein attack as well as $500 million in damages for Clorox and an estimated $200 million lost by Dole.

Henry Schein appears to be the first medtech company that’s suffered a cyberattack since the SEC launched new regulations requiring publicly traded companies to promptly disclose cybersecurity incidents that have a material impact. However, Henry Schein has not yet quantified the impact or said whether it is considered to be material. (These regulations are different than the FDA’s new cybersecurity requirements for developers and manufacturers of cyber devices.)

Medical Design & Outsourcing: Henry Schein’s cybersecurity response offers lessons for others

Filed Under: Business/Financial News, Featured, Legal News, News Well Tagged With: Cybersecurity, Henry Schein, ransomware

More recent news

  • Teleflex wins Breakthrough Device designation for Freesolve resorbable scaffold
  • FDA clears Solventum’s combo wound care platform following Acera acquisition
  • GE HealthCare begins new global partnerships to advance theranostic imaging technology
  • Siemens Healthineers, Nvidia launch radiotherapy AI collaboration
  • J&J, Medtronic present pulsed field ablation data from global real-world use

About Jim Hammerand

Jim Hammerand is the managing editor of Arrowfly's MassDevice and Medical Design & Outsourcing, where he leads coverage of medtech innovation, design, engineering and manufacturing. He also contributes to our Devicetalks podcasts and live events. Hammerand has more than two decades of journalism experience spanning newspapers, magazines, websites, live events, radio and TV news. For nearly a decade, Hammerand reported and edited business news for American City Business Journals as a reporter and digital editor at the Minneapolis/St. Paul Business Journal and then as managing editor of the Puget Sound Business Journal in Seattle. He holds degrees in journalism and management from the University of Minnesota and has won journalism awards from the Society of Professional Journalists, American Society of Business Publication Editors, and Trade, Association, Business Publications International. Connect with him on LinkedIn or by email at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy